2,510
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Danggui Buxue decoction alleviates cyclophosphamide-induced myelosuppression by regulating β-hydroxybutyric acid metabolism and suppressing oxidative stress

, , , , ORCID Icon, , , & show all
Pages 710-721 | Received 29 Sep 2022, Accepted 06 Apr 2023, Published online: 25 Apr 2023

References

  • Adeshakin AO, Yan D, Zhang M, Wang L, Adeshakin FO, Liu W, Wan X. 2020. Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy. Biochem Biophys Res Commun. 522(3):604–611.
  • Brigle K, Pierre A, Finley-Oliver E, Faiman B, Tariman J, Miceli T. 2017. Myelosuppression, bone disease, and acute renal failure: evidence-based recommendations for oncologic emergencies. Clin J Oncol Nurs. 21(5 Suppl):60–76.
  • Castro JP, Jung T, Grune T, Siems W. 2017. 4-Hydroxynonenal (HNE) modified proteins in metabolic diseases. Free Radic Biol Med. 111:309–315.
  • Cristani M, Speciale A, Saija A, Gangemi S, Minciullo P, Cimino F. 2016. Circulating advanced oxidation protein products as oxidative stress biomarkers and progression mediators in pathological conditions related to inflammation and immune dysregulation. Curr Med Chem. 23(34):3862–3882.
  • Gao Y, Li W, Chen J, Wang X, Lv Y, Huang Y, Zhang Z, Xu F. 2019. Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan. Acta Pharm Sin B. 9(1):157–166.
  • Guo Y, Zhang Y, Hou Y, Guo P, Wang X, Zhang S, Yang P. 2021. Anticonstriction effect of MCA in rats by Danggui Buxue Decoction. Front Pharmacol. 12:749915.
  • He M, Wang N, Zheng W, Cai X, Qi D, Zhang Y, Han C. 2021. Ameliorative effects of ginsenosides on myelosuppression induced by chemotherapy or radiotherapy. J Ethnopharmacol. 268:113581.
  • Hiam-Galvez KJ, Allen BM, Spitzer MH. 2021. Systemic immunity in cancer. Nat Rev Cancer. 21(6):345–359.
  • Hou B, Liu R, Qin Z, Luo D, Wang Q, Huang S. 2017. Oral Chinese herbal medicine as an adjuvant treatment for chemotherapy, or radiotherapy, induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2017:3432750.
  • Ito K, Suda T. 2014. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol. 15(4):243–256.
  • Ji L, He Q, Liu Y, Deng Y, Xie M, Luo K, Cai X, Zuo Y, Wu W, Li Q, et al. 2022. Ketone body beta-hydroxybutyrate prevents myocardial oxidative stress in septic cardiomyopathy. Oxid Med Cell Longev. 2022:2513837.
  • Kim MY, Yan B, Huang S, Qiu Y. 2020. Regulating the regulators: the role of histone deacetylase 1 (HDAC1) in erythropoiesis. IJMS. 21(22):8460.
  • Lee JC, Espeli M, Anderson CA, Linterman MA, Pocock JM, Williams NJ, Roberts R, Viatte S, Fu B, Peshu N, et al. 2013. Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell. 155(1):57–69.
  • Lin L, Hron JD, Peng SL. 2004. Regulation of NF-kappaB, th activation, and autoinflammation by the forkhead transcription factor foxo3a. Immunity. 21(2):203–213.
  • Liu H, Yang H, Qin Z, Chen Y, Yu H, Li W, Zhu X, Cai J, Chen J, Zhang M. 2021. Exploration of the Danggui Buxue Decoction mechanism regulating the balance of ESR and AR in the TP53-AKT signaling pathway in the prevention and treatment of POF. Evid Based Complement Alternat Med. 2021:4862164.
  • Liu M, Tan H, Zhang X, Liu Z, Cheng Y, Wang D, Wang F. 2014. Hematopoietic effects and mechanisms of Fufang Ejiao Jiang on radiotherapy and chemotherapy-induced myelosuppressed mice. J Ethnopharmacol. 152(3):575–584.
  • Liu Y, Chang M, Hu Z, Xu X, Wu W, Ning M, Hang T, Song M. 2021. Danggui Buxue Decoction enhances the anticancer activity of gemcitabine and alleviates gemcitabine-induced myelosuppression. J Ethnopharmacol. 273:113965.
  • Marrocco I, Altieri F, Peluso I. 2017. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev. 2017:6501046.
  • Møller N. 2020. Ketone body, 3-hydroxybutyrate: minor metabolite - major medical manifestations. J Clin Endocr Metab. 105(9):2884–2892.
  • Muhaidat J, Albatayneh A, Abdallah R, Papamichael I, Chatziparaskeva G. 2022. Predicting COVID-19 future trends for different European countries using Pearson correlation. EuroMediterr J Environ Integr. 7(2):157–170.
  • Mukaka M. 2012. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 24(3):69–71.
  • Pich O, Muinos F, Lolkema MP, Steeghs N, Gonzalez-Perez A, Lopez-Bigas N. 2019. The mutational footprints of cancer therapies. Nat Genet. 51(12):1732–1740.
  • Qiu H, Cao S, Xu R. 2021. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 41(10):1037–1048.
  • Rosborough BR, Castellaneta A, Natarajan S, Thomson AW, Turnquist HR. 2012. Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo. J Leukoc Biol. 91(5):701–709.
  • Rtibi K, Selmi S, Grami D, Sebai H, Amri M, Marzouki L. 2017. Irinotecan chemotherapy-induced intestinal oxidative stress: underlying causes of disturbed mucosal water and electrolyte transport. Pathophysiology. 24(4):275–279.
  • Samadi M, Aziz SG, Naderi R. 2021. The effect of tropisetron on oxidative stress, SIRT1, FOXO3a, and claudin-1 in the renal tissue of STZ-induced diabetic rats. Cell Stress Chaperones. 26(1):217–227.
  • Sanchez-Rodriguez MA, Mendoza-Nunez VM. 2019. Oxidative stress indexes for diagnosis of health or disease in humans. Oxid Med Cell Longev. 2019:1–32.
  • Serafini M, Villano D, Spera G, Pellegrini N. 2006. Redox molecules and cancer prevention: the importance of understanding the role of the antioxidant network. Nutr Cancer. 56(2):232–240.
  • Shao L, Wang Y, Chang J, Luo Y, Meng A, Zhou D. 2013. Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury. Transl Cancer Res. 2:397–411.
  • Shi X-Q, Zhu Z-H, Yue S-J, Tang Y-P, Chen Y-Y, Pu Z-J, Tao H-J, Zhou G-S, Yang Y, Guo M-J, et al. 2020. Integration of organ metabolomics and proteomics in exploring the blood enriching mechanism of Danggui Buxue Decoction in hemorrhagic anemia rats. J Ethnopharmacol. 261:113000.,.
  • Shimazu T, Hirschey M, Newman J, He W, Shirakawa K, Le Moan N, Grueter C, Lim H, Saunders L, Stevens R, et al. 2013. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 339(6116):211–214.
  • Silva WN, Costa AC, Picoli CC, Rocha BGS, Santos GSP, Costa PAC, Azimnasab-Sorkhabi P, Soltani-Asl M, da Silva RA, Amorim JH, et al. 2021. Hematopoietic stem cell stretches and moves in its bone marrow niche. Crit Rev Oncol Hematol. 163:103368.
  • Sousa BC, Pitt AR, Spickett CM. 2017. Chemistry and analysis of HNE and other prominent carbonyl-containing lipid oxidation compounds. Free Radic Biol Med. 111:294–308.
  • Wei Q, Frenette PS. 2018. Niches for hematopoietic stem cells and their progeny. Immunity. 48(4):632–648.
  • Wishart DS. 2016. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 15(7):473–484.
  • Wishart DS. 2019. Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev. 99(4):1819–1875.
  • Wu Y, Teng Y, Zhang C, Pan Y, Zhang Q, Zhu X, Liu N, Su X, Lin J. 2022. The ketone body beta-hydroxybutyrate alleviates CoCrMo alloy particles induced osteolysis by regulating NLRP3 inflammasome and osteoclast differentiation. J Nanobiotechnology. 20(1):120.
  • Yan S, Liu R, Jin H, Liu X, Ye J, Shan L, Zhang W. 2015. “Omics” in pharmaceutical research: overview, applications, challenges, and future perspectives. Chin J Nat Med. 13(1):3–21.
  • Yang J, Zhu X, Yuan P, Liu J, Wang B, Wang G. 2020. Efficacy of traditional Chinese medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials. Support Care Cancer. 28(8):3571–3579.
  • Yang S, Che H, Xiao L, Zhao B, Liu S. 2021. Traditional Chinese medicine on treating myelosuppression after chemotherapy. Medicine. 100(4):e24307.
  • Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D'Agostino D, Planavsky N, Lupfer C, Kanneganti TD, et al. 2015. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 21(3):263–269.
  • Zhang H, Zhang L, Yang C, Zhang Y, Li J, Zhang X, Chen J, Huang B, Zhao D, Li X, et al. 2022. Prevention effect of protopanaxadiol-type saponins saponins and protopanaxatriol-type saponins on myelosuppression mice induced by cyclophosphamide. Front Pharmacol. 13:845034.